Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 390.68 Million | USD 944.07 Million | 10.3% | 2023 |
According to a report from Zion Market Research, the global Spatial Omics Market was valued at USD 390.68 Million in 2023 and is projected to hit USD 944.07 Million by 2032, with a compound annual growth rate (CAGR) of 10.3% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Spatial Omics Market industry over the next decade.
The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million).
Complicated intercellular interactions and bio-molecular cues from extracellular matrix (ECM) severely impact cell functions. However, conventional proteomic & transcriptomic approaches have offered deeper insights into disease proliferation through identification of discrete cell population along with other pathological issues. Nevertheless, these methods are not able to accurately assess as to how a cellular state can relate interactions with surrounding cells. Moreover, spatial omics methods provide high resolution mapping of expression profiles of cell tissues similar to that provided by mass spectroscopy. Ability to retain spatial content of various cells in samples along with their cellular geometry and surrounding ECM is likely to offer spatial omics with an opportunity of exploring unexplored signal modalities, thereby brining a paradigm shift in ECM research activities & our understanding of fibrotic ailments.
Report Attributes | Report Details |
---|---|
Report Name | Spatial Omics Market |
Market Size in 2023 | USD 390.68 Million |
Market Forecast in 2032 | USD 944.07 Million |
Growth Rate | CAGR of 10.3% |
Number of Pages | 140 |
Key Companies Covered | PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems |
Segments Covered | By Type, By end-user, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive market trends. In addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry in foreseeable future. Rise in allocation of funds in biopharmaceutical sector will enlarge application scope of spatial omics in upcoming years. Nevertheless, low awareness about spatial omics methods in developing economies as well as high device costs will restraint growth of spatial omics industry over forecast timespan.
Furthermore, rapid spread of COVID pandemics has further boosted growth of spatial omics market over assessment period. Breakthroughs in tissue sequencing, gene sequencing, and single cell sequencing have led to evolution of spatial genomic sequencing methods, thereby driving spatial omics market expansion. In addition to this, growth of new techniques for spatial omics is set to produce lucrative avenues for research & diagnostics, thereby enhancing size of spatial omics industry.
North American Market To Acquire Numero Uno Position By 2028
The regional market expansion during forecast timeline can be attributed to rise in cancer cases along with escalating necessity of personalized drugs. Apart from this, presence of robust healthcare infrastructure & amenities and access to new diagnostic methods will define growth of business in sub-continent over assessment period. Rise in rate of mortality owing to surge in cancer, autoimmune disorders, inflammatory ailments, and metabolic diseases will generate need for new medical treatment modes, thereby boosting regional market trends.
Key participants profiled in study and leveraging market growth include
By End-User
By Technique
By Product
By Region
FrequentlyAsked Questions
Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive market trends. In addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry in foreseeable future. Rise in allocation of funds in biopharmaceutical sector will enlarge application scope of spatial omics in upcoming years.
According to Zion market research report, the global Spatial Omics Market was valued at USD 390.68 Million in 2023 and is projected to hit USD 944.07 Million by 2032, with a compound annual growth rate (CAGR) of 10.3% during the forecast period 2024-2032.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to rise in cancer cases along with escalating necessity of personalized drugs.
The key market participants include PerkinElmer, Inc., Dovetail Genomics, IonPath, Inc., Nanostring Technologies, Inc., Seven Bridges Genomics, Danaher Corporation, Bio-Techne, Akoya Biosciences, Inc., Diagenode Diagnostics, S2 Genomics, Inc., Biognosys AG, Vizgen Corporation, Bruker Corporation, Brooks Automation, Inc., BioSpyder Technologies, and Rebus Biosystems.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed